publication venue for
- Real-world comparison of effectiveness between ustekinumab and a second-line anti-TNF agent in patients with symptomatic stricturing Crohn’s disease failing to respond to a first-line anti-TNF agent: the USTEKNOSIS study. 18:17562848251389476. 2025
- A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease. 15:17562848221082879. 2022